In a mental health crisis? Call or text 988. Emergency: 911.

Patient questions

Is TMS worth considering if antidepressants and therapy haven't relieved my depression?

If you have tried medication, and therapy, and you are still not feeling better, that is not a sign you have run out of options. It is usually the point where a broader evaluation, including whether TMS fits, becomes worth having.

Short answer: For some people whose depression has not improved with antidepressants and therapy, FDA-cleared TMS is a reasonable next option to raise with a psychiatrist. It is not a replacement for medication or therapy outright. The National Institute of Mental Health notes that brain-stimulation treatment plans may include medication or psychotherapy alongside it. Whether it is the right next step depends on your treatment history, current symptoms, and a clinical evaluation, not on a general rule that applies to everyone.

What "hasn't worked" actually means

Depression is generally considered treatment-resistant when it has not responded to at least two different antidepressants, each taken at an adequate dose for an adequate length of time. According to Mayo Clinic, antidepressants typically take four to eight weeks to become fully effective, so a trial that was cut short, underdosed, or never really given time is a different situation from one that was tried properly and still didn't help.

This distinction matters because the next step depends on it. A psychiatrist's first job, before recommending anything, is confirming what you actually tried: which medications, at what dose, for how long, and what happened when therapy was added. That review is not a formality. It is what separates ordinary trial-and-error from a pattern worth addressing more directly.

Where TMS fits into that picture

Repetitive transcranial magnetic stimulation (rTMS), which NIMH describes as a noninvasive treatment using magnetic pulses to stimulate the brain, is FDA-cleared for some people whose depression has not improved with other treatment. It does not require anesthesia or sedation, and it does not circulate through the bloodstream the way a pill does, which changes the side-effect profile compared with another medication switch.

Published research on standard rTMS for depression that has not responded to medication generally reports remission in roughly 30 to 36 percent of patients, with response rates (meaningful symptom improvement, short of full remission) higher than that. These figures describe groups of patients in studies, not a guarantee for any one person. A psychiatrist can walk through how they apply to a specific history.

What TMS does not replace

TMS is not usually presented as a stand-alone substitute for therapy or medication management. NIMH's guidance is that brain-stimulation treatment plans may include medication or psychotherapy as part of the same plan, not instead of it. For many patients, medication management continues during a TMS course, with dosing reviewed rather than dropped outright, and therapy continues in parallel.

What a decision actually depends on

  • What you have already tried. Which antidepressants, at what dose, for how long, and what the response was. Which therapy approaches, and with what outcome.
  • The clinical picture now. Current symptom severity, safety considerations, medical history, and any other diagnoses that might change the recommendation.
  • What the evidence supports for your situation. The research base is different for major depression, OCD, and other conditions; a clinician should explain the relevant evidence and its limits, not just the headline numbers.
  • Practical fit. A standard TMS course runs roughly six weeks of outpatient, weekday sessions. That schedule needs to be realistic for your life, not just clinically appropriate.
  • Insurance and cost. Coverage varies by plan. Benefits should be verified and explained before you commit to a course, not after.

None of this is a case for skipping the conversation with a psychiatrist and deciding on your own that TMS is or isn't right. It is a case for having that conversation with enough information to ask good questions. (See our seven questions to ask before starting TMS for a practical checklist.)

How NeuPath approaches this question

NeuPath TMS & Psychiatry is a boutique clinic in Long Beach offering TMS, medication management, and talk therapy under one coordinated plan. When a patient says medication and therapy haven't been enough, that is treated as the start of a real evaluation, not a signal to jump straight to a recommendation. The first appointment runs forty-five to sixty minutes, long enough to review prior treatment history in detail rather than skim it.

Our care team includes Dr. Samer Roumani, D.O., a dual board-certified psychiatrist and Medical Director, and Richard Perez, PMHNP-BC, a board-certified psychiatric-mental health nurse practitioner. We verify insurance benefits before scheduling treatment and explain expected cost in plain terms beforehand. If your history points toward a path other than TMS, we say so.

Ready to talk through your history?

The first call is short and practical. We ask about prior treatment, current symptoms, insurance, and schedule, and decide together whether a clinical evaluation makes sense.